Harrow Health (HROWL) Stock Price, News & Analysis
Company Description
Harrow Health (HROWL) is a publicly traded company.
HROWL stock has gained 0.0% over the past year.
On a trailing twelve-month basis, Harrow Health reported revenue of $272.3M with net income of -$5.1M and diluted earnings per share of $-0.14. The company operates at a net profit margin of -1.9%.
This page provides a comprehensive overview of HROWL stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
HROWL Rankings
Latest News
SEC Filings
Harrow Health has filed 5 recent SEC filings, including 4 Form 4, 1 Form 8-K. The most recent filing was submitted on June 3, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all HROWL SEC filings →
Financial Highlights
Harrow Health generated $272.3M in revenue over the trailing twelve months, retaining a 75.0% gross margin, operating income reached $30.5M (11.2% operating margin), and net income was -$5.1M, reflecting a -1.9% net profit margin. Diluted earnings per share stood at $-0.14. The company generated $43.9M in operating cash flow. With a current ratio of 2.20, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Harrow Health (HROWL) currently stands at 184 shares, a new position with no short interest reported in the previous period, representing 0.0% of the shares outstanding. Over the past 12 months, short interest has decreased by 90.7%.
Days to Cover History
Days to cover for Harrow Health (HROWL) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.